Literature DB >> 8636533

Time course of cytokine levels in sepsis.

L G Thijs1, C E Hack.   

Abstract

In severe sepsis, a network of proinflammatory cytokines (TNF, IL-1 beta, IL-6, IL-8) is activated and blood levels of these cytokines are elevated, albeit inconsistently and with large individual variations. In addition, elevated blood levels of anti-inflammatory cytokines (IL-10), as well as of soluble cytokine receptors (sTNF-RI and II, IL-1ra), have been found. They seem to have a regulatory function in the host response. Levels of TNF and IL-6 are usually highest at the time of admission, whereas the time course of IL-1 beta levels (when detectable) can vary considerably. Limited data on IL-8 levels suggest that they may remain elevated for longer periods. Elevated levels of sTNFR and IL-1ra may also persist for a prolonged period of time. The pathogenetic significance of these observations is still unclear, but persistingly high levels of proinflammatory cytokines may be associated with organ failure and mortality.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8636533     DOI: 10.1007/bf01740764

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  30 in total

1.  Plasma tumor necrosis factor levels in patients with presumed sepsis. Results in those treated with antilipid A antibody vs placebo.

Authors:  M A de Groote; M A Martin; P Densen; M A Pfaller; R P Wenzel
Journal:  JAMA       Date:  1989-07-14       Impact factor: 56.272

2.  High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome.

Authors:  S Chollet-Martin; P Montravers; C Gibert; C Elbim; J M Desmonts; J Y Fagon; M A Gougerot-Pocidalo
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

3.  Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients.

Authors:  M A Rogy; S M Coyle; H S Oldenburg; C S Rock; P S Barie; K J Van Zee; C G Smith; L L Moldawer; S F Lowry
Journal:  J Am Coll Surg       Date:  1994-02       Impact factor: 6.113

4.  Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever.

Authors:  J G Cannon; R G Tompkins; J A Gelfand; H R Michie; G G Stanford; J W van der Meer; S Endres; G Lonnemann; J Corsetti; B Chernow
Journal:  J Infect Dis       Date:  1990-01       Impact factor: 5.226

5.  Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality.

Authors:  M R Pinsky; J L Vincent; J Deviere; M Alegre; R J Kahn; E Dupont
Journal:  Chest       Date:  1993-02       Impact factor: 9.410

6.  Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection.

Authors:  J S Friedland; Y Suputtamongkol; D G Remick; W Chaowagul; R M Strieter; S L Kunkel; N J White; G E Griffin
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

7.  Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group.

Authors:  E Girardin; P Roux-Lombard; G E Grau; P Suter; H Gallati; J M Dayer
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

8.  Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels.

Authors:  C H Wortel; M A von der Möhlen; S J van Deventer; C L Sprung; M Jastremski; M J Lubbers; C R Smith; I E Allen; J W ten Cate
Journal:  J Infect Dis       Date:  1992-12       Impact factor: 5.226

9.  High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group.

Authors:  T Calandra; J Gerain; D Heumann; J D Baumgartner; M P Glauser
Journal:  Am J Med       Date:  1991-07       Impact factor: 4.965

10.  Interleukin-10 production during septicaemia.

Authors:  A Marchant; J Devière; B Byl; D De Groote; J L Vincent; M Goldman
Journal:  Lancet       Date:  1994-03-19       Impact factor: 79.321

View more
  33 in total

1.  Clinical study on therapy of clearing hallow viscera in treating critical patients with gastro-enteric function disorder.

Authors:  Sheng-lan Yang; Dao-ben Li
Journal:  Chin J Integr Med       Date:  2006-06       Impact factor: 1.978

Review 2.  Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.

Authors:  Kenneth L Becker; Richard Snider; Eric S Nylen
Journal:  Br J Pharmacol       Date:  2009-11-27       Impact factor: 8.739

3.  Reductions in frontocortical cytokine levels are associated with long-lasting alterations in reward valuation after methamphetamine.

Authors:  Alexandra Stolyarova; Andrew B Thompson; Ruth M Barrientos; Alicia Izquierdo
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

Review 4.  Obesity: "priming" the lung for injury.

Authors:  Jason Konter; Elizabeth Baez; Ross S Summer
Journal:  Pulm Pharmacol Ther       Date:  2012-03-17       Impact factor: 3.410

5.  Kinetics of serum cytokines after primary or repeat vaccination with the smallpox vaccine.

Authors:  Jeffrey I Cohen; Patricia Hohman; Rachael Fulton; Siu-Ping Turk; Jing Qin; Karen Thatcher; Ronald L Hornung
Journal:  J Infect Dis       Date:  2010-04-15       Impact factor: 5.226

6.  Effect of N-acetylcysteine and fructose-1,6-bisphosphate in the treatment of experimental sepsis.

Authors:  Ricardo Obalski de Mello; Adroaldo Lunardelli; Eduardo Caberlon; Cristina Machado Bragança de Moraes; Roberto Christ Vianna Santos; Vinicius Lorini da Costa; Gabriela Viegas da Silva; Patrícia da Silva Scherer; Luiz Eduardo Coimbra Buaes; Denizar Alberto da Silva Melo; Márcio Vinícius Fagundes Donadio; Fernanda Bordignon Nunes; Jarbas Rodrigues de Oliveira
Journal:  Inflammation       Date:  2011-12       Impact factor: 4.092

7.  Multiplexed protein profiling on microarrays by rolling-circle amplification.

Authors:  Barry Schweitzer; Scott Roberts; Brian Grimwade; Weiping Shao; Minjuan Wang; Qin Fu; Quiping Shu; Isabelle Laroche; Zhimin Zhou; Velizar T Tchernev; Jason Christiansen; Mark Velleca; Stephen F Kingsmore
Journal:  Nat Biotechnol       Date:  2002-04       Impact factor: 54.908

8.  Effect of L-NAME, an inhibitor of nitric oxide synthesis, on plasma levels of IL-6, IL-8, TNF alpha and nitrite/nitrate in human septic shock.

Authors:  J A Avontuur; T C Stam; M Jongen-Lavrencic; J G van Amsterdam; A M Eggermont; H A Bruining
Journal:  Intensive Care Med       Date:  1998-07       Impact factor: 17.440

9.  The prognostic value of atrial and brain natriuretic peptides, troponin I and C-reactive protein in patients with sepsis.

Authors:  Tuba Yucel; Dilek Memiş; Beyhan Karamanlioglu; Necdet Süt; Mahmut Yuksel
Journal:  Exp Clin Cardiol       Date:  2008

10.  Inflammasome mRNA expression in human monocytes during early septic shock.

Authors:  Ruairi J Fahy; Matthew C Exline; Mikhail A Gavrilin; Nitin Y Bhatt; Beth Y Besecker; Anasuya Sarkar; Jennifer L Hollyfield; Michelle D Duncan; Haikady N Nagaraja; Nina L Knatz; Mark Hall; Mark D Wewers
Journal:  Am J Respir Crit Care Med       Date:  2008-02-08       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.